1. A BCMA-specific CAR T cell produced with clinically scalable lentiviral and T cell manufacturing processes has potent anti-multiple myeloma activity. Issue 2 (December 2015) Authors: Garrett, Tracy; Chekmasova, Alena; Evans, John; Seidel, Stacie; Horton, Holly; Latimer, Howard; Griecci, Johanna; Horvath, Christopher; Ryu, Byoung; Friedman, Kevin; Morgan, Richard Journal: Journal for immunotherapy of cancer Issue: Volume 3:Issue 2(2015) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗